Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use
申请人:Boehringer Ingelheim Pharma KG
公开号:US06362210B1
公开(公告)日:2002-03-26
Carboxylic acid amides of general formula
which inhibit telomerase and are useful for treating tumour diseases such as carcinomas, sarcomas and leukaemias. Exemplary compounds are:
(1) trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide, and,
(2) trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-4,5-dimethoxy-phenyl)-amide.
通用公式为的羧酸酰胺,抑制端粒酶,可用于治疗癌症、肉瘤和白血病等肿瘤疾病。示例化合物包括:
(1) 反-3-(萘-2-基)-丁-2-烯酸-N-(2-羧基苯基)-酰胺,以及,
(2) 反-3-(萘-2-基)-丁-2-烯酸-N-(2-羧基-4,5-二甲氧基苯基)-酰胺。